Doxycycline controlled release - Promius Pharma

Drug Profile

Doxycycline controlled release - Promius Pharma

Alternative Names: DFD 09; Doxycycline modified release - Promius Pharma; Modified release oral tetracycline - Promius Pharma; Zenavod

Latest Information Update: 03 May 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Promius Pharma
  • Class Antibacterials; Antimalarials; Skin disorder therapies; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Rosacea

Most Recent Events

  • 21 Apr 2018 Pharmacokinetics data from a clinical trial in Healthy volunteers presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
  • 30 Nov 2017 Doxycycline controlled release is still tentatively approved in the US
  • 08 Apr 2015 Preregistration for Rosacea in USA (PO) ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top